Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Intrinsic Value
The intrinsic value of one DAWN stock under the Base Case scenario is 10.82 USD. Compared to the current market price of 10.43 USD, Day One Biopharmaceuticals Inc is Undervalued by 4%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Day One Biopharmaceuticals Inc.
Wall St
Price Targets
DAWN Price Targets Summary
Day One Biopharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DAWN is 23.12 USD with a low forecast of 17.17 USD and a high forecast of 30.45 USD.
The intrinsic value of one DAWN stock under the Base Case scenario is 10.82 USD.
Compared to the current market price of 10.43 USD, Day One Biopharmaceuticals Inc is Undervalued by 4%.